Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study

Multiple Sclerosis Journal

Volumn 17, Issue 8, 2011, Pages 991-1001

  Patti, F ^a   Amato, M P ^b   Trojano, M ^c   Bastianello, S ^d   Tola, M R ^e   Picconi, O ^f   Cilia, S ^f   Cottone, S ^g   Centonze, D ^h   Gasperini, C ⁱ  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^e UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^f Opera CRO Scientific Advisory Board   (Italy)

^g Centro Di Riferimento Regionale di Neuroimmunologia   (Italy)

^h TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

ⁱ SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

cognitive function; depression; fatigue; interferon beta 1a; longitudinal study; quality of life; relapsing remitting multiple sclerosis

Indexed keywords

BETA1A INTERFERON;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; HUMAN; MULTICENTER STUDY; MULTIPLE SCLEROSIS; QUALITY OF LIFE; RATING SCALE;

EID: 80051991717     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511401943     Document Type: Article

References (42)

1. Ghaffar O, Feinstein A. The neuropsychiatry of multiple sclerosis: a review of recent developments. Curr Opin Psychiatry. 2007 ; 20: 278-285 (Pubitemid 46588302)
2. Turpin KV, Carroll LJ, Cassidy JD, Hader WJ. Deterioration in the health-related quality of life of persons with multiple sclerosis: the possible warning signs. Mult Scler. 2007 ; 13: 1038-1345
3. Foley JF, Brandes DW. Redefining functionality and treatment efficacy in multiple sclerosis. Neurology. 2009 ; 72 (Suppl). S1 - S11
4. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ. 1997 ; 314: 1580-1583 (Pubitemid 27229105)
5. Arnett PA, Higginson CI, Voss WD, Bender WI, Wurst JM, Tippin JM. Depression in multiple sclerosis: relationship to working memory capacity. Neuropsychology. 1999 ; 13: 546-556 (Pubitemid 29474643)
6. Lester K, Stepleman L, Hughes M. The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population. J Behav Med. 2007 ; 30: 177-186 (Pubitemid 46426945)
7. Patrick E, Christodoulou C, Krupp LB. Longitudinal correlates of fatigue in multiple sclerosis. Mult Scler. 2009 ; 15: 258-261
8. Penner IK, Bechtel N, Raselli C, Stocklin M, Opwis K, Kappos L, et al. Fatigue in multiple sclerosis: relation to depression, physical impairment, personality and action control. Mult Scler. 2007 ; 13: 1161-1167 (Pubitemid 351541420)
9. Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler. 2001 ; 7: 340-344 (Pubitemid 33026260)
10. Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci. 2002 ; 205: 51-58 (Pubitemid 36158993)
11. Patti F, Cacopardo M, Palermo F, Ciancio MR, Lopes R, Restivo D, et al. Health-related quality of life and depression in an Italian sample of multiple sclerosis patients. J Neurol Sci. 2003 ; 211: 55-62 (Pubitemid 36593268)
12. Simone IL, Ceccarelli A, Tortorella C, Bellacosa A, Pellegrini F, Plasmati I, et al. Influence of interferon beta treatment on quality of life in multiple sclerosis patients. Health Qual Life Outcomes. 2006 ; 4: 96-96
13. Ziemssen T. Multiple sclerosis beyond EDSS: depression and fatigue. J Neurol Sci. 2009 ; 277 (Suppl. 1). S37 - S41
14. Arnett PA, Barwick FH, Beeney JE. Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc. 2008 ; 14: 691-724
15. Pittion-Vouyovitch S, Debouverie M, Guillemin F, Vandenberghe N, Anxionnat R, Vespignani H. Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci. 2006 ; 243: 39-45
16. Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci. 2006 ; 245: 41-46 (Pubitemid 43775956)
17. Patti F, Amato M, Trojano M, Bastianello S, Tola M, Goretti B, et al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler. 2009 ; 15: 779-788
18. Patti F. Cognitive impairment in multiple sclerosis. Mult Scler. 2009 ; 15: 2-8
19. Simioni S, Ruffieux C, Bruggimann L, Annoni JM, Schluep M. Cognition, mood and fatigue in patients in the early stage of multiple sclerosis. Swiss Med Wkly. 2007 ; 137: 496-501 (Pubitemid 47441800)
20. Andreasen AK, Spliid PE, Andersen H, Jakobsen J. Fatigue and processing speed are related in multiple sclerosis. Eur J Neurol. 2010 ; 17: 212-218
21. Glanz BI, Healy BC, Rintell DJ, Jaffin SK, Bakshi R, Weiner HL. The association between cognitive impairment and quality of life in patients with early multiple sclerosis. J Neurol Sci. 2010 ; 290: 75-79
22. Winkelmann A, Engel C, Apel A, Zettl UK. Cognitive impairment in multiple sclerosis. J Neurol. 2007 ; 254 (Suppl. 2). II35 - II42
23. Patti F, Amato MP, Bastianello S, Caniatti L, Di Monte E, Ferrazza P, et al. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Mult Scler. 2010 ; 16: 68-77
24. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. 4 th edn Washington, DC: American Psychiatric Publishing ; 1994 :
25. Amato MP, Portaccio E, Goretti B, Zipoli V, Ricchiuti L, De Caro MF, et al. The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler. 2006 ; 12: 787-793 (Pubitemid 46111772)
26. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967 ; 6: 278-296
27. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994 ; 18 (Suppl. 1). S79 - S83
28. Mellerup E, Fog T, Raun N, Colville P, De Rham B, Hannah B, et al. The socio-economic scale. Acta Neurol Scand. 1981 ; 64: 130-138
29. Colombo L, Sartori G, Brivio C. La stima del quoziente intellettivo tramite l'applicazione del TIB (Test di Intelligenza Breve). G Ital Psicol. 2002 ; 3: 613-637
30. Rudick RA, Miller D, Hass S, Hutchinson M, Calabresi PA, Confavreux C, et al. Health-related quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol. 2007 ; 62: 335-346 (Pubitemid 350105948)
31. Jongen PJ, Sindic C, Carton H, Zwanikken C, Lemmens W, Borm G. Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a. J Neurol. 2010 ; 257: 584-589
32. Wu N, Minden SL, Hoaglin DC, Hadden L, Frankel D. Quality of life in people with multiple sclerosis: data from the Sonya Slifka Longitudinal Multiple Sclerosis Study. J Health Hum Serv Adm. 2007 ; 30: 233-267
33. Zivadinov R, Zorzon M, Tommasi MA, Nasuelli D, Bernardi M, Monti-Bragadin L, et al. A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a. J Neurol Sci. 2003 ; 216: 113-118 (Pubitemid 37371875)
34. Lobentanz IS, Asenbaum S, Vass K, Sauter C, Klosch G, Kollegger H, et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand. 2004 ; 110: 6-13 (Pubitemid 38850550)
35. Putzki N, Fischer J, Gottwald K, Reifschneider G, Ries S, Siever A, et al. Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis. Eur J Neurol. 2009 ; 16: 713-720
36. Sumowski JF, Wylie GR, Chiaravalloti N, DeLuca J. Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis. Neurology. 2010 ; 74: 1942-1945
37. Patti F, Pozzilli C, Montanari E, Pappalardo A, Piazza L, Levi A, et al. Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis. Mult Scler. 2007 ; 13: 783-791 (Pubitemid 47074103)
38. Hopman WM, Coo H, Pavlov A, Day AG, Edgar CM, McBride EV, et al. Multiple sclerosis: change in health-related quality of life over two years. Can J Neurol Sci. 2009 ; 36: 554-561
39. Morrow SA, Weinstock-Guttman B, Munschauer FE, Hojnacki D, Benedict RH. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis. Mult Scler. 2009 ; 15: 998-1005
40. Bakshi R, Czarnecki D, Shaikh ZA, Priore RL, Janardhan V, Kaliszky Z, et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport. 2000 ; 11: 1153-1158 (Pubitemid 30262949)
41. Benedict RH, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci. 2005 ; 231: 29-34 (Pubitemid 40432023)
42. Good K, Clark CM, Oger J, Paty D, Klonoff H. Cognitive impairment and depression in mild multiple sclerosis. J Nerv Ment Dis. 1992 ; 180: 730-732 (Pubitemid 23009556)